IP Library › Granted Patent US 12,727,775
Granted Patent B2
US 12,727,775 · App. 19/011,057 · Granted Sep 8, 2026

Portable device for quantitative measurement of tissue autoregulation and neurovascular coupling using EEG, metabolism, and blood flow diagnostics

Inventors: Yama Akbari (Irvine, CA); Robert H. Wilson (Irvine, CA); Christian Crouzet (Irvine, CA); Thomas Milner (Irvine, CA); Bernard Choi (Irvine, CA)
Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
A61B5/0261A61B5/0075A61B5/14553A61B5/6801
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,727,775
App. No.
19/011,057
Granted
Sep 8, 2026
Kind
B2
Abstract

A portable device for quantitative measurement of tissue autoregulation and neurovascular coupling via portable measurement of blood flow, oxygenation, metabolism, and/or EEG signals and methods for using said device. The device may comprise a body and a plurality of legs pivotably attached to the body. The plurality of legs may comprise at least one reference electrode leg and at least one measurement electrode leg for electrical measurement, and an optical detection fiber leg and at least one optical source fiber leg for optical blood flow, oxygenation, and metabolism measurement. The present invention is additionally directed to a portable device for blood flow measurement and therapeutic photobiomodulation. The device may comprise a body and a plurality of legs. The plurality of legs may comprise at least one optical detection fiber leg and at least one optical source fiber leg, and at least one leg for therapeutic photobiomodulation.

Claims (13)

1 . A method of determining an absolute value of cerebral metabolic rate of oxygen (CMRO 2 ) using a volumetric calibration, the method comprising:

a. positioning one or more light sources and two or more detectors in proximity to a head of a subject;

b. emitting a coherent light signal from one or more of the light sources into the head, such that one or more backscattered light signals are generated;

c. detecting one or more of the backscattered light signals via the two or more detectors, wherein the detected signals correspond to an optically measured volume of tissue;

d. calculating a tissue absorption coefficient and a tissue scattering coefficient from the detected signals;

e. calculating a calibrated perfusion metric representing perfusion over an area of the volume of tissue from the detected signals;

f. calculating a deoxygenated hemoglobin concentration (ctHb) in the volume of tissue from the tissue absorption coefficient;

g. calculating a mean penetration depth of the detected signals, using the tissue absorption coefficient and tissue scattering coefficient; and

h. calculating an absolute value of CMRO 2 from the deoxygenated hemoglobin concentration, the calibrated perfusion metric, and the mean penetration depth.

2 . The method of claim 1 , wherein the tissue absorption coefficient and tissue scattering coefficient are determined via Spatial Frequency Domain Imaging (SFDI), Diffuse Optical Spectroscopy (DOS), or Near Infrared Spectroscopy (NIRS).

3 . The method of claim 1 , wherein the calibrated perfusion metric is determined via Laser Speckle Imaging (LSI), Diffuse Correlation Spectroscopy (DCS), or Laser Doppler Imaging (LDI).

4 . The method of claim 1 , wherein the calibrated perfusion metric is determined via calibration of a dynamic perfusion metric using the tissue absorption coefficient and the tissue scattering coefficient.

5 . The method of claim 4 , wherein the dynamic perfusion metric comprises a speckle flow index (SFI) or a blood flow index (BFI), and the calibrated perfusion metric comprises a Brownian diffusion coefficient (Db), a directed flow speed (v c ), a cerebral blood flow (CBF) or a combination thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2025
From: AKBARI, YAMA; WILSON, ROBERT H.; CROUZET, CHRISTIAN; MILNER, THOMAS; CHOI, BERNARD
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 073197/0232 →
Continuity (8)
Division 17377123 · Jul 15, 2021
Continuation In Part 16985113 · Aug 4, 2020
Continuation In Part PCTUS2020035440 · May 29, 2020
Continuation In Part 16837478 · Apr 1, 2020
Provisional Application 63032491 · May 29, 2020
Provisional Application 62854215 · May 29, 2019
Provisional Application 62827668 · Apr 1, 2019
Related Publication 20250134405A1 · May 1, 2025
References Cited (89)
US 4709702A · Sherwin · 1987 [cited by applicant]
US 6251587B1 · Sevigny et al. · 2001 [cited by applicant]
US 6280393B1 · Granger et al. · 2001 [cited by applicant]
US 6466816B2 · Granger et al. · 2002 [cited by applicant]
US D739122S · Aimone et al. · 2015 [cited by applicant]
US 9730649B1 · Jepsen · 2017 [cited by applicant]
US 10009644B2 · Aimone et al. · 2018 [cited by applicant]
US 10321842B2 · Garten et al. · 2019 [cited by applicant]
US 20020133087A1 · Bayer et al. · 2002 [cited by applicant]
US 20030004557A1 · Neuberger et al. · 2003 [cited by applicant]
US 20030050537A1 · Wessel · 2003 [cited by applicant]
US 20040068199A1 · Echauz et al. · 2004 [cited by applicant]
US 20050143589A1 · Donoghue et al. · 2005 [cited by applicant]
US 20050228692A1 · Hodgdon · 2005 [cited by applicant]
US 20060281983A1 · Al-ali et al. · 2006 [cited by applicant]
US 20070191689A1 · Elitok · 2007 [cited by applicant]
US 20080177572A1 · Fuhrman et al. · 2008 [cited by applicant]
US 20080243022A1 · Donnett et al. · 2008 [cited by applicant]
US 20080249430A1 · Hiesiger et al. · 2008 [cited by applicant]
US 20090062685A1 · Bergethon et al. · 2009 [cited by applicant]
US 20090118622A1 · Durkin et al. · 2009 [cited by applicant]
US 20090181006A1 · Dambinova · 2009 [cited by applicant]
US 20100241100A1 · Blumenfeld et al. · 2010 [cited by applicant]
US 20110105912A1 · Widman et al. · 2011 [cited by applicant]
US 20120143020A1 · Bordoley et al. · 2012 [cited by applicant]
US 20130261183A1 · Bhagat · 2013 [cited by applicant]
US 20140018649A1 · Jespersen et al. · 2014 [cited by applicant]
US 20140088996A1 · Damani · 2014 [cited by applicant]
US 20140316218A1 · Purdon et al. · 2014 [cited by applicant]
US 20150051521A1 · Woerlee et al. · 2015 [cited by applicant]
US 20150257674A1 · Jordan et al. · 2015 [cited by applicant]
US 20160310049A1 · Rowe et al. · 2016 [cited by applicant]
US 20160317385A1 · Salcido et al. · 2016 [cited by applicant]
US 20160345880A1 · Nakaji et al. · 2016 [cited by applicant]
US 20170135594A1 · Hartings et al. · 2017 [cited by applicant]
US 20170224246A1 · Jiang et al. · 2017 [cited by applicant]
US 20180044278A1 · Bazan et al. · 2018 [cited by applicant]
US 20180085047A1 · Hartings et al. · 2018 [cited by applicant]
US 20180103861A1 · Sutin et al. · 2018 [cited by applicant]
US 20180246570A1 · Coleman et al. · 2018 [cited by applicant]
US 20180308390A1 · Moser et al. · 2018 [cited by applicant]
US 20190053721A1 · Boas et al. · 2019 [cited by applicant]
US 20190113973A1 · Coleman et al. · 2019 [cited by applicant]
US 20190117500A1 · Shaw et al. · 2019 [cited by applicant]
US 20190159675A1 · Sengupta et al. · 2019 [cited by applicant]
US 20190306438A1 · Regan et al. · 2019 [cited by applicant]
US 20190306439A1 · Morales Delgado et al. · 2019 [cited by applicant]
US 20190384392A1 · Aimone et al. · 2019 [cited by applicant]
US 20200019243A1 · Aimone et al. · 2020 [cited by applicant]
US 20200057075A1 · Hinman et al. · 2020 [cited by applicant]
US 20200367761A1 · Akbari et al. · 2020 [cited by applicant]
CN 113268142A · 2021 [cited by examiner]
DE 10153360A1 · 2003 [cited by applicant]
EP 3020333A1 · 2016 [cited by applicant]
EP 3857509B1 · 2023 [cited by examiner]
WO 2008109699A2 · 2008 [cited by applicant]
WO 2016164891A1 · 2016 [cited by applicant]
WO 2020243658A1 · 2020 [cited by applicant]
Cuccia et al., “Quantitation and Mapping of Tissue Optical Properties Using Modulated Imaging”, Journal of Biomedical Optics, vol. 14, No. 2, Mar./Apr. 2009, 13 pages. [cited by applicant]
Dreier et al., “Spreading Depolarization Is Not an Epiphenomenon But The Principal Mechanism of The Cytotoxic Edema In Various Gray Matter Structures of The Brain During Stroke”, vol. 134, May 15, 2018, pp. 189-207. [cited by applicant]
EPO, “Extended European Search Report”, issued in connection with European Patent Application No. 20813099.7 dated Sep. 27, 2023, 10 pages. [cited by applicant]
Kofman et al. “Dual-Wavelength Laser Speckle Imaging for Monitoring Brain Metabolic and Hemodynamic Response to Closed Head Traumatic Brain Injury in Mice”, Journal of Biomedical Optics, vol. 20, No. 10, Oct. 2015, pp. … [cited by applicant]
Krachunov et al., “3D Printed Dry EEG Electrodes”, Sensors, Journal, 1635, vol. 16, doi:10.3390/s16101635, Oct. 2016, pp. 1-18. [cited by applicant]
Lellouche et al., “Sudden Cardiac Arrest: ECG Repolarization After Resuscitation” Journal of Cardiovascular Electrophysiology, vol. 22, No. 2, 2011, pp. 131-136. [cited by applicant]
Mortberg et al., “Cerebral Metabolic Rate Of Oxygen (CMRO2) In Pig Brain Determined By PET After Resuscitation From Cardiac Arrest”, vol. 80, No. 6, Jun. 1, 2009, pp. 701-706. [cited by applicant]
Puttgen et al., “Predicting Neurological Outcome Following Cardiac Arrest”, Journal Of The Neurological Sciences, vol. 261, 2007, pp. 108-117. [cited by applicant]
Salvo et al. “A 3D Printed Dry Electrode For ECG/EEG Recording”, Sensors and Actuators A: Physical, vol. 174, Dec. 8, 2011, pp. 96-102. [cited by applicant]
Sinha et al., “Monitoring the Brain After Cardiac Arrest: A New Era”, Current Neurology and Neuroscience Reports, DOI 10.1007/s11910-017-0770-x, vol. 17, Article 62, Jul. 1, 2017, 11 pages. [cited by applicant]
Temple et al., “Predicting Neurological Outcome and Survival After Cardiac Arrest.” Continuing Education in Anaesthesia Critical Care & Pain, vol. 12, Issue 6, Dec. 2012, pp. 283-287. [cited by applicant]
USPTO, “Advisory Action”, issued in connection with U.S. Appl. No. 17/277,616 dated Oct. 10, 2024, 5 pages. [cited by applicant]
USPTO, “Final Office Action”, issued in connection with U.S. Appl. No. 16/985,113 dated Mar. 15, 2021, 30 pages. [cited by applicant]
USPTO, “Final Office Action”, issued in connection with U.S. Appl. No. 17/277,616 dated Aug. 14, 2024, 18 pages. [cited by applicant]
USPTO, “Non-Final Office Action”, issued in connection with U.S. Appl. No. 16/985,113 dated Oct. 30, 2020, 22 pages. [cited by applicant]
USPTO, “Non-Final Office Action”, issued in connection with U.S. Appl. No. 17/277,616 dated Dec. 11, 2024, 19 pages. [cited by applicant]
USPTO, “Non-Final Office Action”, issued in connection with U.S. Appl. No. 17/277,616 dated Jan. 18, 2024, 19 pages. [cited by applicant]
USPTO, “Non-Final Office Action”, issued in connection with U.S. Appl. No. 17/735,903 dated Feb. 27, 2025, 25 pages. [cited by applicant]
USPTO, “Notice of Allowance”, issued in connection with U.S. Appl. No. 17/377,123 dated Sep. 29, 2024, 13 pages. [cited by applicant]
USPTO, “Notice of Allowance”, issued in connection with U.S. Appl. No. 17/690,866 dated Jan. 24, 2025, 17 pages. [cited by applicant]
Wiebe et al., “Eeg-Pen for Medical Emergencies”, Biomedical Engineering / Biomedizinische Technik, https://doi.org/10.1515/bmte.2002.47.s1a.308, Oct. 23, 2009, vol. 47, Issue s1a, 2 pages. [cited by applicant]
WIPO, “International Preliminary Report on Patentability” issued in connection with PCT Patent Application PCT/US2019/052486, dated Apr. 1, 2021, 6 pages. [cited by applicant]
WIPO, “International Preliminary Report on Patentability” issued in connection with PCT Patent Application PCT/US2020/053144, dated Apr. 7, 2022, 9 pages. [cited by applicant]
WIPO, “International Preliminary Report on Patentability” issued in connection with PCT Patent Application PCT/US2020/35440, dated Dec. 9, 2021, 8 pages. [cited by applicant]
WIPO, “International Preliminary Report on Patentability” issued in connection with PCT Patent Application PCT/US2022/37361, dated Jan. 25, 2024, 10 pages. [cited by applicant]
WIPO, “International Search Report and Written Opinion” issued in connection with PCT Patent Application PCT/US2019/052486, dated Nov. 19, 2019, 7 pages. [cited by applicant]
WIPO, “International Search Report and Written Opinion” issued in connection with PCT Patent Application PCT/US2020/053144, dated Mar. 9, 2021, 12 pages. [cited by applicant]
WIPO, “International Search Report and Written Opinion” issued in connection with PCT Patent Application PCT/US2020/35440, dated Oct. 15, 2020, 11 pages. [cited by applicant]
WIPO, “International Search Report and Written Opinion” issued in connection with PCT Patent Application PCT/US2022/37361, dated Oct. 13, 2022, 11 pages. [cited by applicant]
WIPO, “Invitation to Pay Additional Fees” issued in connection with PCT Patent Application PCT/US2020/053144, dated Nov. 16, 2020, 2 pages. [cited by applicant]
USPTO, “Final Office Action”, issued in connection with U.S. Appl. No. 17/735,903 dated Jan. 26, 2026, 28 pages. [cited by applicant]